FDA approves Boston's Rio aspiration catheter

4 June 2006

US medical device developer Boston Scientific says that it has received clearance from the Food and Drug Administration to market its Rio aspiration catheter. The new device, which is the latest addition to the firm's line of vascular protection products, is indicated for use in the removal of thrombi and clots from vessels throughout the body.

The product is comprised of two tubular cavities, one of which contains a wire that is used to position the catheter, while the other is used to extract blockages when a syringe is used to apply suction. Hank Kucheman, president of the company's interventional cardiology business, said that the product is a versatile means of restoring blood flow and that it improves visibility during intravascular interventions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight